Sarcoma  >>  ONCT-216  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ONCT-216 / Oncternal Therap
NCT05046314: A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma

Recruiting
2
30
RoW
TK216+Vincristin
Shanghai Pharmaceuticals Holding Co., Ltd
Sarcoma, Ewing
09/25
12/25
TK216-01, NCT02657005: TK216 in Patients With Relapsed or Refractory Ewing Sarcoma

Terminated
1/2
85
US
TK216
Oncternal Therapeutics, Inc
Sarcoma, Ewing
05/22
06/22

Download Options